BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25211222)

  • 61. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
    Downer EJ; Johnston DG; Lynch MA
    Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects.
    Kim MH; Yoo DS; Lee SY; Byeon SE; Lee YG; Min T; Rho HS; Rhee MH; Lee J; Cho JY
    Pharmazie; 2011 Apr; 66(4):293-300. PubMed ID: 21612158
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-β signaling.
    Bourgeois C; Majer O; Frohner IE; Lesiak-Markowicz I; Hildering KS; Glaser W; Stockinger S; Decker T; Akira S; Müller M; Kuchler K
    J Immunol; 2011 Mar; 186(5):3104-12. PubMed ID: 21282509
    [TBL] [Abstract][Full Text] [Related]  

  • 64. TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1.
    Lee Y; Song B; Park C; Kwon KS
    PLoS One; 2013; 8(5):e63255. PubMed ID: 23675467
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis.
    Lundberg AM; Ketelhuth DF; Johansson ME; Gerdes N; Liu S; Yamamoto M; Akira S; Hansson GK
    Cardiovasc Res; 2013 Jul; 99(2):364-73. PubMed ID: 23417039
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SOCS1 regulates the IFN but not NFkappaB pathway in TLR-stimulated human monocytes and macrophages.
    Prêle CM; Woodward EA; Bisley J; Keith-Magee A; Nicholson SE; Hart PH
    J Immunol; 2008 Dec; 181(11):8018-26. PubMed ID: 19017994
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
    Hirotani T; Yamamoto M; Kumagai Y; Uematsu S; Kawase I; Takeuchi O; Akira S
    Biochem Biophys Res Commun; 2005 Mar; 328(2):383-92. PubMed ID: 15694359
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
    Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
    Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation.
    Cusson-Hermance N; Khurana S; Lee TH; Fitzgerald KA; Kelliher MA
    J Biol Chem; 2005 Nov; 280(44):36560-6. PubMed ID: 16115877
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stimulator of IFN gene is critical for induction of IFN-beta during Chlamydia muridarum infection.
    Prantner D; Darville T; Nagarajan UM
    J Immunol; 2010 Mar; 184(5):2551-60. PubMed ID: 20107183
    [TBL] [Abstract][Full Text] [Related]  

  • 71. TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules.
    Matsunaga N; Tsuchimori N; Matsumoto T; Ii M
    Mol Pharmacol; 2011 Jan; 79(1):34-41. PubMed ID: 20881006
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition.
    Wang JP; Liu P; Latz E; Golenbock DT; Finberg RW; Libraty DH
    J Immunol; 2006 Nov; 177(10):7114-21. PubMed ID: 17082628
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling.
    Schoenemeyer A; Barnes BJ; Mancl ME; Latz E; Goutagny N; Pitha PM; Fitzgerald KA; Golenbock DT
    J Biol Chem; 2005 Apr; 280(17):17005-12. PubMed ID: 15695821
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells.
    Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
    J Leukoc Biol; 2010 Jan; 87(1):117-25. PubMed ID: 19843574
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The TRAF-associated protein TANK facilitates cross-talk within the IkappaB kinase family during Toll-like receptor signaling.
    Clark K; Takeuchi O; Akira S; Cohen P
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17093-8. PubMed ID: 21949249
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
    Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG
    J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression.
    Reily MM; Pantoja C; Hu X; Chinenov Y; Rogatsky I
    EMBO J; 2006 Jan; 25(1):108-17. PubMed ID: 16362036
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Optineurin insufficiency impairs IRF3 but not NF-κB activation in immune cells.
    Munitic I; Giardino Torchia ML; Meena NP; Zhu G; Li CC; Ashwell JD
    J Immunol; 2013 Dec; 191(12):6231-40. PubMed ID: 24244017
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Toll/IL-1 domain-containing adaptor inducing IFN-β (TRIF) mediates innate immune responses in murine peritoneal mesothelial cells through TLR3 and TLR4 stimulation.
    Hwang EH; Kim TH; Oh SM; Lee KB; Yang SJ; Park JH
    Cytokine; 2016 Jan; 77():127-34. PubMed ID: 26579632
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM.
    Hise AG; Daehnel K; Gillette-Ferguson I; Cho E; McGarry HF; Taylor MJ; Golenbock DT; Fitzgerald KA; Kazura JW; Pearlman E
    J Immunol; 2007 Jan; 178(2):1068-76. PubMed ID: 17202370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.